Quest Diagnostics Names Tracy L. Cinco-Abela Vice President and Treasurer
MADISON, N.J., Feb. 11, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Tracy L. Cinco-Abela has been named vice president and treasurer.
Ms. Cinco-Abela has responsibility for all treasury activities, including capital planning, capital markets and funding, financial risk management and treasury operations. Most recently, she served as the company's assistant treasurer. She reports to Robert A. Hagemann, senior vice president and chief financial officer.
"Tracy's extensive treasury and finance experience, combined with her successful leadership of major capital raising and deployment initiatives for Quest Diagnostics, makes her a superb choice to be our next treasurer," said Hagemann.
Ms. Cinco-Abela joined Quest Diagnostics in 2007. Prior to that, she held positions of increasing responsibility for the General Motors Treasurer's Office, where she gained considerable experience in capital planning and funding, foreign exchange and commodities, cash management and treasury operations.
Ms. Cinco-Abela earned her MBA from The Kellogg School of Management at Northwestern University and an undergraduate degree from De La Salle University in Manila, Philippines.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.
Quest Diagnostics Contacts:
Dan Haemmerle (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics
More by this Source
Quest Diagnostics Declares Quarterly Cash Dividend
May 21, 2013, 14:16 ET
Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds
May 13, 2013, 14:58 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.